Sales soar at Danish firm behind weight-loss drug semaglutide

[ad_1] The maker of blockbuster weight-loss drug semaglutide has reported a steep rise in sales and profits as health systems around the world rush to use it to tackle obesity.…

Woman shares what happened after she stopped taking semaglutide

[ad_1] For Meredith Schorr, a registered nurse, working in the medical field during the coronavirus pandemic, took both a mental and physical toll. “I wasn’t thinking about how to integrate…

The obesity drugs waiting to hit the market

[ad_1] Novo Nordisk said a large study had shown its highly effective obesity drug Wegovy also had a clear cardiovascular benefit, boosting the Danish drugmaker’s hopes of moving beyond Wegovy’s…